GUTS
FRACTYL HEALTH, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.38
−10.97%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$1.50
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.12
- EPS estimate
- -$0.14
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +52.7%
- Revenue beats (12Q)
- 0
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.14 | -$0.12 | Beat 11.11% | — |
| May 12, 2026 | -$0.17 | -$0.13 | Beat 23.53% | — |
| Mar 24, 2026 | -$0.19 | $0.15 | Beat 178.95% | — |
| Nov 12, 2025 | -$0.34 | -$0.35 | Miss -2.94% | — |
| Aug 12, 2025 | -$0.37 | -$0.53 | Miss -43.24% | — |
| Mar 3, 2025 | -$0.44 | -$0.52 | Miss -18.18% | $3.0K |
| Aug 14, 2024 | -$0.46 | -$0.36 | Beat 21.74% | $43.0K |
| Apr 1, 2024 | -$0.65 | -$8.02 | Miss -1133.85% | $7.0K |
| Sep 29, 2023 | — | -$0.33 | — | $36.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026